Guillermo Velasco - Complutense University of Madrid

基本信息

浏览量：0

职业迁徙

个人简介

BSc and MSc in Biology at Complutense University, Madrid, Spain (1993) PhD in Biochemistry at Complutense University, Madrid, Spain (1997) Post Doc at MRC Unit, Dundee University, Scotland, UK (1998, 1999) Assitant teacher of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain (2000-2008) Associate Professor of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain (2008 - )

研究兴趣

论文共 195 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Belzutifan Versus Everolimus in Participants (pts) with Previously Treated Advanced Renal Cell Carcinoma (RCC): Patient-reported Outcomes (pros) in the Phase 3 LITESPARK-005 Study

Thomas Powles,Laurence Albiges, Katriina Johanna Jalkanen,Guillermo De Velasco,Mauricio Burotto, Pooja Ghatalia,Cristina Suarez, Elaine T. Lam, Roberto Iacovelli, Mahmut Gumus,Elena Verzoni,Christian K. Kollmannsberger, Walter Michael Stadler,Balaji Venugopal, Reshma Shinde, Todd L. Saretsky, Li He,Donna Vickery,Toni K. Choueiri,Brian I. Rini

JOURNAL OF CLINICAL ONCOLOGYno. 4_SUPPL (2024): 361-361

引用0浏览0引用

Safety Profile of Belzutifan Monotherapy in Patients with Renal Cell Carcinoma: A Pooled Analysis of 4 Clinical Trials

Toni K. Choueiri,Pooja Ghatalia,Guillermo de Velasco,Laurence Albiges,Mauricio Burotto,Cristina Suarez,James Brugarolas,Roberto Iacovelli, Katriina Jalkanen,Elaine T. Lam,Ramaprasad Srinivasan,Jaime Merchan,Neeraj Agarwal,Ane B. Iversen,Brian Rini,Todd M. Bauer,Howard Gurney,Othon Iliopoulos,Jianxin Lin, Liis Starkopf, Margarita Donica, Olga Gumieniak,Donna Vickery,Yanfang Liu,Rodolfo F. Perini,Thomas Powles,Eric Jonasch

ONCOLOGIST (2024)

引用0浏览0引用

Meta-analysis of Perioperative Immune Checkpoint Inhibitors in Urothelial and Renal Cell Carcinoma: Data from the Latest Available Evidence

Jorge Esteban Villarrubia, Torres, Maria Ruiz Vico, Pablo Alvarez-Ballesteros,Daniel Castellano,Guillermo de Velasco

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies

Giulia Ambrosini,Marco Cordani,Ali Zarrabi,Sergio Alcon-Rodriguez,Rosa M. Sainz,Guillermo Velasco,Pedro Gonzalez-Menendez,Ilaria Dando

Cell communication and signaling : CCS（2024）

引用0浏览0WOS引用

Cytotoxicity, Proapoptotic Activity and Drug-like Potential of Quercetin and Kaempferol in Glioblastoma Cells: Preclinical Insights

Magdalena Kusaczuk, Elena Tovar-Ambel, Paola Martin-Cabrera,Mar Lorente, Nelida Salvador-Tormo,Agnieszka Miklosz,Adrian Chabowski,Guillermo Velasco,Monika Naumowicz

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESno. 19 (2024)

引用0浏览0WOS引用

Systemic Treatments in Favorable and Very Favorable Risk Metastatic Renal Cell Carcinoma (mrcc): Real World Evidence from the International Mrcc Database Consortium (IMDC)

Martin Zarba, Evan Ferrier,Connor Wells, Talal El Zarif, Naveen S. Basappa,Hedyeh Ebrahimi,Rana R. Mckay,Lori Wood,Benoit Beuselinck,Cristina Suarez, Kosuke Takemura, Aly-Khan A. Lalani, Haoran Li,Lavinia Anne Spain, Arnoud J. Templeton,Thomas Powles,Georg A. Bjarnason,Guillermo de Velasco,Toni K. Choueiri, Daniel Yick Chin Heng

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

ADU-1604, a Novel CTLA-4 Blocking Antibody, to Modulate Pharmacodynamic Markers in Patients with PD1 Relapse/refractory Melanoma

Guillermo De Velasco, Piotr Rutkowski, Anna Maria Di Giacomo, Ana Maria Arance,Caroline Robert, Vanna Chiarion-Sileni,Ivan Marquez-Rodas, Jessica Kundapur, Julien Villaudy, Hans van Eenennaam, Laura Lassouw-Polman, Alexander M. Eggermont

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Dynamic Profiling in Patients with Metastatic Clear Cell Renal Cell Carcinoma (mrcc) Undergoing First-Line Treatment with Cabozantinib: A Sub-Exploratory Analysis from CABOPRE Trial